436 related articles for article (PubMed ID: 26087276)
1. Development of live attenuated Streptococcus agalactiae vaccine for tilapia via continuous passage in vitro.
Li LP; Wang R; Liang WW; Huang T; Huang Y; Luo FG; Lei AY; Chen M; Gan X
Fish Shellfish Immunol; 2015 Aug; 45(2):955-63. PubMed ID: 26087276
[TBL] [Abstract][Full Text] [Related]
2. Spatiotemporal distribution of Streptococcus agalactiae attenuated vaccine strain YM001 in the intestinal tract of tilapia and its effect on mucosal associated immune cells.
Huang T; Li LP; Liu Y; Luo YJ; Wang R; Tang JY; Chen M
Fish Shellfish Immunol; 2019 Apr; 87():714-720. PubMed ID: 30738148
[TBL] [Abstract][Full Text] [Related]
3. Development of an attenuated oral vaccine strain of tilapia Group B Streptococci serotype Ia by gene knockout technology.
Li L; Liu Y; Huang T; Liang W; Chen M
Fish Shellfish Immunol; 2019 Oct; 93():924-933. PubMed ID: 31374315
[TBL] [Abstract][Full Text] [Related]
4. Development of attenuated erythromycin-resistant Streptococcus agalactiae vaccine for tilapia (Oreochromis niloticus) culture.
Liu L; Lu DQ; Xu J; Luo HL; Li AX
J Fish Dis; 2019 May; 42(5):693-701. PubMed ID: 30893488
[TBL] [Abstract][Full Text] [Related]
5. Comparative genome analysis identifies two large deletions in the genome of highly-passaged attenuated Streptococcus agalactiae strain YM001 compared to the parental pathogenic strain HN016.
Wang R; Li L; Huang Y; Luo F; Liang W; Gan X; Huang T; Lei A; Chen M; Chen L
BMC Genomics; 2015 Nov; 16():897. PubMed ID: 26537657
[TBL] [Abstract][Full Text] [Related]
6. Large-scale profiling of the proteome and dual transcriptome in Nile tilapia (Oreochromis niloticus) challenged with low- and high-virulence strains of Streptococcus agalactiae.
Zhou Y; Liu Y; Luo Y; Zhong H; Huang T; Liang W; Xiao J; Wu W; Li L; Chen M
Fish Shellfish Immunol; 2020 May; 100():386-396. PubMed ID: 32165249
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Streptococcus agalactiae (group B) vaccine in tilapia (Oreochromis niloticus) by intraperitoneal and bath immersion administration.
Evans JJ; Klesius PH; Shoemaker CA
Vaccine; 2004 Sep; 22(27-28):3769-73. PubMed ID: 15315858
[TBL] [Abstract][Full Text] [Related]
8. Development of live attenuated Streptococcus agalactiae as potential vaccines by selecting for resistance to sparfloxacin.
Pridgeon JW; Klesius PH
Vaccine; 2013 May; 31(24):2705-12. PubMed ID: 23583891
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of live attenuated vaccine derived from the Streptococcus agalactiae on the immune responses of Oreochromis niloticus.
Laith AA; Abdullah MA; Nurhafizah WWI; Hussein HA; Aya J; Effendy AWM; Najiah M
Fish Shellfish Immunol; 2019 Jul; 90():235-243. PubMed ID: 31009810
[TBL] [Abstract][Full Text] [Related]
10. An effective live attenuated vaccine against Streptococcus agalactiae infection in farmed Nile tilapia (Oreochromis niloticus).
Zhang D; Gao Y; Li Q; Ke X; Liu Z; Lu M; Shi C
Fish Shellfish Immunol; 2020 Mar; 98():853-859. PubMed ID: 31751658
[TBL] [Abstract][Full Text] [Related]
11. Duration of protective antibodies and correlation with survival in Nile tilapia Oreochromis niloticus following Streptococcus agalactiae vaccination.
Pasnik DJ; Evans JJ; Klesius PH
Dis Aquat Organ; 2005 Sep; 66(2):129-34. PubMed ID: 16231638
[TBL] [Abstract][Full Text] [Related]
12. Multiomics analyses reveal that NOD-like signaling pathway plays an important role against Streptococcus agalactiae in the spleen of tilapia.
Wu W; Li L; Liu Y; Huang T; Liang W; Chen M
Fish Shellfish Immunol; 2019 Dec; 95():336-348. PubMed ID: 31586680
[TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of an oral DNA vaccine encoding Sip of Streptococcus agalactiae from Nile tilapia Oreochromis niloticus delivered by live attenuated Salmonella typhimurium.
Huang LY; Wang KY; Xiao D; Chen DF; Geng Y; Wang J; He Y; Wang EL; Huang JL; Xiao GY
Fish Shellfish Immunol; 2014 May; 38(1):34-41. PubMed ID: 24631734
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory responses of Nile tilapia Oreochromis niloticus to Streptococcus agalactiae: effects of vaccination and yeast diet supplement.
Salvador R; Toazza CS; de Moraes JR; de Moraes FR
Dis Aquat Organ; 2012 Apr; 98(3):235-41. PubMed ID: 22535873
[TBL] [Abstract][Full Text] [Related]
15. Construction of Streptococcus agalactiae sialic acid mutant and evaluation of its potential as a live attenuated vaccine in Nile tilapia (Oreochromis niloticus).
Hao J; Wang S; Wei Z; Zhang Q; Wu Z; Lin Y; Yang J; Zhang J; Zhang D; Li A
J Appl Microbiol; 2022 Oct; 133(4):2403-2416. PubMed ID: 35801502
[TBL] [Abstract][Full Text] [Related]
16. Construction of a Streptococcus iniae sortase A mutant and evaluation of its potential as an attenuated modified live vaccine in Nile tilapia (Oreochromis niloticus).
Wang J; Zou LL; Li AX
Fish Shellfish Immunol; 2014 Oct; 40(2):392-8. PubMed ID: 25090938
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive evaluation of immunomodulation by moderate hypoxia in S. agalactiae vaccinated Nile tilapia.
Gallage S; Katagiri T; Endo M; Maita M
Fish Shellfish Immunol; 2017 Jul; 66():445-454. PubMed ID: 28526572
[TBL] [Abstract][Full Text] [Related]
18. Protective efficacy of cationic-PLGA microspheres loaded with DNA vaccine encoding the sip gene of Streptococcus agalactiae in tilapia.
Ma YP; Ke H; Liang ZL; Ma JY; Hao L; Liu ZX
Fish Shellfish Immunol; 2017 Jul; 66():345-353. PubMed ID: 28476676
[TBL] [Abstract][Full Text] [Related]
19. Comparative multi-omics systems analysis reveal the glycolysis / gluconeogenesis signal pathway play an important role in virulence attenuation in fish-derived GBS YM001.
Liu Y; Li L; Huang T; Wang R; Liang W; Yang Q; Lei A; Chen M
PLoS One; 2019; 14(8):e0221634. PubMed ID: 31449567
[TBL] [Abstract][Full Text] [Related]
20. GapA, a potential vaccine candidate antigen against Streptococcus agalactiae in Nile tilapia (Oreochromis niloticus).
Zhang Z; Yu A; Lan J; Zhang H; Hu M; Cheng J; Zhao L; Lin L; Wei S
Fish Shellfish Immunol; 2017 Apr; 63():255-260. PubMed ID: 28219739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
